Brain immune-cell models reveal opposite effects from the same gene
Researchers grew brain immune-cell models from 261 human stem cell lines to connect genetic differences with gene activity, movement and debris clearance. The peer-reviewed study combines population genetics with gene-disruption experiments. One gene’s effects run in opposite directions in two immune-cell models, highlighting how cellular context changes the experimental response in this laboratory system.
Science··Evening
From genetic variation to cell behaviour
A team grew microglia-like cells from 261 human stem cell lines to investigate genetic effects on brain immune-cell functions. Microglia move through brain tissue and remove biological debris. The peer-reviewed paper and the British Wellcome Sanger Institute describe experiments linking genetic variation with gene activity, movement and debris clearance. The cells were laboratory models, assessed both without stimulation and under two conditions mimicking inflammatory immune responses.[1], [2]
Shared genetic signals
The researchers connected gene-expression associations with genetic studies of Alzheimer’s disease, Parkinson’s disease, multiple sclerosis and amyotrophic lateral sclerosis. They identified 79 regions where disease-associated and gene-expression signals overlap statistically. The experimental programme also targeted 251 genes using CRISPR, a gene-editing technique that can disrupt selected genes. This added functional tests to associations between naturally occurring variants and the laboratory cells’ behaviour.[1]
One gene, opposite responses
Disrupting TREM2, a gene involved in immune-cell function, increased the debris-processing signal in microglia-like cells but decreased it in macrophage-like cells, another immune-cell model. The readout includes uptake and subsequent processing, not engulfment alone. Additional gene-suppression approaches tested the contrast. The laboratory results depend on cell type and environment; predominantly European donors and incomplete reproduction of the brain environment further constrain their application to human disease.[1]